​
​

Bellevue Life Sciences Acquisition Ownership 2024 | Who Owns Bellevue Life Sciences Acquisition Now?

OverviewFinancialsChart

Institutional Ownership

100.00%

Insider Ownership

51.98%

Retail Ownership

-51.98%

Institutional Holders

22.00

Bellevue Life Sciences Acquisition Mutual Fund Holders

Name% Total AssetsTotal SharesChange AmountChange %Date
RIVERNORTH OPPORTUNITIES FUND, INC.0.04%54,328--Jan 31, 2024
RiverNorth Specialty Finance Corp0.03%28,66728,667-Sep 30, 2023
Saba Capital Income & Opportunities Fund0.01%14,638--Jan 31, 2024
FIRST TRUST ALTERNATIVE OPPORTUNITIES FUND0.00%16,328--Dec 31, 2023
Franklin Alternative Strategies Funds0.00%22,684--Feb 29, 2024

Bellevue Life Sciences Acquisition's largest mutual fund holder by % of total assets is "RIVERNORTH OPPORTUNITIES FUND, INC.", owning 54.33K shares, compromising 0.04% of its total assets.

Bellevue Life Sciences Acquisition Institutional Ownership Trends

Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 2322-

As of 31 Mar 23, 22 institutions are holding Bellevue Life Sciences Acquisition's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 233,224,140-

Bellevue Life Sciences Acquisition (BLAC) has 3.22M shares outstanding as of 31 Mar 23, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 23100.00%-

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 23--

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 23--

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 2322-3,224,140-100.00%-----

Bellevue Life Sciences Acquisition Insider Shareholders Trades

Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 27, 2023Hwang Kuk Hyoundirector, 10 percent owner, officer Chief Executive OfficerJ-OtherSell20,000--2,000,500
Mar 27, 2023Hwang Kuk Hyoundirector, 10 percent owner, officer Chief Executive OfficerJ-OtherSell20,000$11.50$230.00K370,000
Mar 27, 2023Bellevue Global Life Science Investors LLC10 percent owner-J-OtherSell20,000--2,000,500
Mar 27, 2023Bellevue Global Life Science Investors LLC10 percent owner-J-OtherSell20,000$11.50$230.00K370,000
Feb 23, 2023Hwang Kuk Hyoundirector, 10 percent owner, officer Chief Executive OfficerJ-OtherSell4,500--2,020,500
Feb 23, 2023Bellevue Global Life Science Investors LLC10 percent owner-J-OtherSell4,500--2,020,500
Feb 16, 2023Bellevue Global Life Science Investors LLC10 percent owner-J-OtherSell20,000--1,705,000
Feb 16, 2023Bellevue Global Life Science Investors LLC10 percent owner-J-OtherSell20,000--1,685,000

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 27, 2023Hwang Kuk Hyoundirector, 10 percent owner, officer Chief Executive OfficerJ-OtherSell20,000--2,000,500
Mar 27, 2023Hwang Kuk Hyoundirector, 10 percent owner, officer Chief Executive OfficerJ-OtherSell20,000$11.50$230.00K370,000
Mar 27, 2023Yoo David Jinofficer Chief Financial OfficerA-AwardBuy20,000--20,000
Mar 27, 2023Yoo David Jinofficer Chief Financial OfficerA-AwardBuy20,000$11.50$230.00K20,000
Mar 27, 2023Bellevue Global Life Science Investors LLC10 percent owner-J-OtherSell20,000--2,000,500
Mar 27, 2023Bellevue Global Life Science Investors LLC10 percent owner-J-OtherSell20,000$11.50$230.00K370,000
Feb 23, 2023Hwang Kuk Hyoundirector, 10 percent owner, officer Chief Executive OfficerJ-OtherBuy225,000--2,025,000
Feb 23, 2023Hwang Kuk Hyoundirector, 10 percent owner, officer Chief Executive OfficerJ-OtherSell4,500--2,020,500
Feb 23, 2023Bellevue Global Life Science Investors LLC10 percent owner-J-OtherBuy225,000--2,025,000
Feb 23, 2023Bellevue Global Life Science Investors LLC10 percent owner-J-OtherSell4,500--2,020,500
Feb 16, 2023REED STEVENdirector-A-AwardBuy20,000--20,000
Feb 16, 2023REED STEVENdirector-A-AwardBuy20,000$11.50$230.00K20,000
Feb 16, 2023Chung In Chuldirector-A-AwardBuy20,000--20,000
Feb 16, 2023Chung In Chuldirector-A-AwardBuy20,000$11.50$230.00K20,000
Feb 16, 2023Roberts Raddirector-A-AwardBuy20,000--20,000
Feb 16, 2023Park Jin Whandirector-A-AwardBuy20,000--20,000
Feb 16, 2023Euh Hosundirector-A-AwardBuy20,000--20,000
Feb 16, 2023Bellevue Global Life Science Investors LLC10 percent owner-A-AwardBuy430,000$10.00$4.30M1,800,000
Feb 16, 2023Bellevue Global Life Science Investors LLC10 percent owner-J-OtherSell20,000--1,705,000
Feb 16, 2023Bellevue Global Life Science Investors LLC10 percent owner-J-OtherSell20,000--1,685,000

The last insider sell of Bellevue Life Sciences Acquisition's stock was made by Hwang Kuk Hyoun on Mar 27 2023, selling 20,000 shares at - per share (valued at -).

Bellevue Life Sciences Acquisition Insider Ownership Trends

All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 2023152755.56%

15 total buy trades, and 27 total sell trades (buy/sell ratio of 0.56%) were made by Bellevue Life Sciences Acquisition's insiders, as of Q1 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 20232--

As of Q1 2023, Insider owners conducted 2 open market buy trades and 0 open market sell trades of Bellevue Life Sciences Acquisition's stocks.

BLAC Ownership FAQ

Bellevue Life Sciences Acquisition is owned by institutional shareholders (100.00%), insiders (51.98%), and public (-51.98%). The largest institutional shareholder of Bellevue Life Sciences Acquisition is (0% of total shares) and the top mutual fund owner is RIVERNORTH OPPORTUNITIES FUND, INC. (0.04% of total shares).

As of Mar 2023, there are 22 institutional shareholders of Bellevue Life Sciences Acquisition.